REGN vs. MRK
Compare and contrast key facts about Regeneron Pharmaceuticals, Inc. (REGN) and Merck & Co., Inc. (MRK).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: REGN or MRK.
Key characteristics
| REGN | MRK | |
|---|---|---|
| YTD Return | 0.56% | 21.11% |
| 1Y Return | 11.47% | 17.05% |
| 3Y Return (Ann) | 21.58% | 24.96% |
| 5Y Return (Ann) | 20.80% | 15.90% |
| 10Y Return (Ann) | 11.44% | 12.29% |
| Sharpe Ratio | 0.66 | 1.08 |
| Daily Std Dev | 20.48% | 17.41% |
| Max Drawdown | -91.81% | -68.63% |
| Current Drawdown | -11.09% | -0.57% |
Fundamentals
| REGN | MRK | |
|---|---|---|
| Market Cap | $98.44B | $318.60B |
| EPS | $34.80 | $0.14 |
| PE Ratio | 25.77 | 898.43 |
| PEG Ratio | 1.46 | 0.10 |
| Revenue (TTM) | $13.12B | $60.12B |
| Gross Profit (TTM) | $7.02B | $42.08B |
| EBITDA (TTM) | $4.65B | $8.30B |
Correlation
The correlation between REGN and MRK is 0.24, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
REGN vs. MRK - Performance Comparison
In the year-to-date period, REGN achieves a 0.56% return, which is significantly lower than MRK's 21.11% return. Over the past 10 years, REGN has underperformed MRK with an annualized return of 11.44%, while MRK has yielded a comparatively higher 12.29% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
REGN vs. MRK - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Regeneron Pharmaceuticals, Inc. (REGN) and Merck & Co., Inc. (MRK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
REGN vs. MRK - Dividend Comparison
REGN has not paid dividends to shareholders, while MRK's dividend yield for the trailing twelve months is around 2.29%.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
REGN Regeneron Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
MRK Merck & Co., Inc. | 2.29% | 2.72% | 2.52% | 3.41% | 3.03% | 2.48% | 2.60% | 3.36% | 3.14% | 3.42% | 3.11% | 3.45% |
Drawdowns
REGN vs. MRK - Drawdown Comparison
The maximum REGN drawdown since its inception was -91.81%, which is greater than MRK's maximum drawdown of -68.63%. Use the drawdown chart below to compare losses from any high point for REGN and MRK. For additional features, visit the drawdowns tool.
Volatility
REGN vs. MRK - Volatility Comparison
Regeneron Pharmaceuticals, Inc. (REGN) and Merck & Co., Inc. (MRK) have volatilities of 4.04% and 4.12%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Financials
REGN vs. MRK - Financials Comparison
This section allows you to compare key financial metrics between Regeneron Pharmaceuticals, Inc. and Merck & Co., Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities